Acute tolerance to continuously infused alfentanil: The role of cholecystokinin and N-methyl-D-aspartate-nitric oxide systems

Anesthesia and Analgesia

Volumn 91, Issue 1, 2000, Pages 110-116

  Kissin, Igor ^a   Bright, Cheryl A ^a   Bradley Jr , Edwin L ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 4 [[2 [2 [[(2 ADAMANTYLOXY)CARBONYL]AMINO] 3 (1H INDOL 3 YL) 2 METHYLPROPIONAMIDO] 1 PHENYLETHYL]AMINO] 4 OXOBUTYRIC ACID MEGLUMINE; ALFENTANIL; CHOLECYSTOKININ; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROGLUMIDE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG TOLERANCE; FACILITATION; INFUSION PUMP; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING;

EID: 0033947669     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/00000539-200007000-00021     Document Type: Article

References (30)

1. Cox BM, Ginsburgh M, Osman OH. Acute tolerance to narcotic analgesic drugs in rats. Br J Pharmacol 1968;33:245-56.
2. Kissin I, Brown PT, Robinson CA, Bradley EL Jr. Acute tolerance in morphine analgesia: continuous infusion and single injection in rats. Anesthesiology 1991;74:166-71.
3. Fairbanks C, Wilcox GL. Acute tolerance to spinally administered morphine compares mechanistically with chronically induced morphine tolerance. J Pharmacol Exp Ther 1997;282: 1408-17.
4. Vinik HR, Kissin I. Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg 1998;86: 1307-11.
5. Kissin I, Lee SS, Arthur GR, Bradley EL Jr. Time course characteristics of acute tolerance development to continuously infused alfentanil in rats. Anesth Analg 1996;83:600-5.
6. Cox BM. Opioid receptor-g protein interactions: acute and chronic effects of opioids. In: Herz A, ed. Handbook of experimental pharmacology. Vol 104. New York: Springer-Verlag, 1993:145-88.
7. Duttaroy A, Yoburn BC. The effect of intrinsic efficacy on opioid tolerance. Anethesiology 1995;82:1226-36.
8. Sofuoglu M, Takemori AE. Naloxone produces protracted tolerance in mice treated with a single dose of morphine. J Pharmacol Exp Ther 1990;254:836-40.
9. Langerman L, Zakowski MI, Piskoun B, Grant GJ. Hot plate versus tail flick: evaluation of acute tolerance to continuous morphine infusion in the rat model. J Pharmacol Toxicol Methods 1995;34:23-7.
10. Bilsky EJ, Inturrisi CE, Sadée W, et al. Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective μ, or δ opioid agonists in mice. Pain 1995;68:229-37.
11. Watkins LR, Kinsche IB, Mayer DJ. Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide. Science 1984;224:395-6.
12. Tang J, Chou J, Iadarola M, et al. Proglumide prevents and curtails acute tolerance to morphine in rats. Neuropharmacology 1984;23:715-8.
13. Dourish CT, O'Neill MF, Coughlan J, et al. The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat. Eur J Pharmacol 1990; 176:35-44.
14. B eceptors, prevents morphine tolerance in the rat. Br J Pharmacol 1992;105:591-6.
15. Lucas GA, Alster P, Brodin E, Wiesenfeld-Hallin Z. Differential release of cholecystokinin by morphine in rat spinal cord. Neurosci Lett 1998;245:13-6.
16. Stanfa L, Dickenson A, Xu X-J, Weisenfeld-Hallin Z. Cholecystokinin and morphine analgesia: variations on a theme. Trends Pharmacol Sc 1994;15:65-6.
17. Trujillo KA, Akil H. Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science 1991;251:85-7.
18. Manning BH, Mao J, Frenk H, et al. Continuous coadministration of dextromethorphan or MK-801 with morphine: attenuation of morphine dependence and naloxone-reversible attenuation of morphine tolerance. Pain 1996;67:79-88.
19. Dunbar S, Yaksh TL. Concurrent spinal infusion of MK801 blocks spinal tolerance and dependence induced by chronic intrathecal morphine in the rat. Anesthesiology 1996;84: 1177-88.
20. G-nitro-L-arginine prevents morphine tolerance. Eur J Pharmacol 1992;221: 399-400.
21. Green AF, Young PA. A comparison of heat and pressure analgesiometric methods in rats. Br J Pharmacol 1951;6:572-85.
22. Carmer SG, Swanson MR. An evaluation of ten pairwise multiple comparison procedure by Monte Carlo methods. J Am Stat Assoc 1973;68:66-74.
23. Chen IW, Dorley JM, Ramjit HG, et al. Physiological disposition and metabolism of L-365,260, a potent antagonist of brain cholecystokinin receptor, in laboratory animals. Drug Metab Dispos 1992;20:390-5.
24. Hoffman O, Wiesenfeld-Hallin Z. The CCK-B receptor antagonist CI 988 reverses tolerance to morphine in rats. Neuroreport 1994;5:2565-8.
25. Feng J, Kendig JJ. N-Methyl-D-aspartate receptors are implicated in hyperresponsiveness following naloxone reversal of alfentanil in isolated rat spinal cord. Neurosci Lett 1995;189: 128-30.
26. Feng J, Kendig J. Selective effects of alfentanil on nociceptive-related neurotransmission in neonatal rat spinal cord. Br J Anaesth 1995;74:691-6.
27. Hucker HB, Hutt JE, White SD, et al. Disposition and metabolism of (+)-5-memyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine in rats, dogs, and monkeys. Drug Metab Dispos 1983;11: 54-8.
28. Iadecola C, Xu X, Zhang F, et al. Prolonged inhibition of brain nitric oxide synthase by short-term systemic administration of nitro-L-arginine methyl ester. Neurochem Res 1994;19:501-5.
29. Kolesnikov YA, Pan Y-X, Babey A-M, et al. Functionally differentiating two neuronal nitric oxide synthase isoforms through antisense mapping: evidence for opposing NO actions on morphine analgesia and tolerance. Proc Natl Acad Sci USA 1997;94: 8820-5.
30. Koob GF, Bloom FE. Cellular and molecular mechanisms of drug dependence. Science 1988;242:715-24.